MOG and myeloid sarcoma: The role that anti‐MOG antibodies might be playing in this disease model is intriguing due to their association with other neurological conditions such as pediatric MS, neuromyelitis optica in AQP‐4 antibody‐negative cases and occasionally anti‐NMDA‐receptor encephalitis (Havla et al., 2017).